Bevacizumab (Ingredient)
Drugbank ID: DB00112
ATC code: L01XC07
The information below refers to products available in the United States that contain bevacizumab.
Products containing bevacizumab
bevacizumab systemic
Brand names: Avastin, Mvasi, Zirabev, Alymsys, Vegzelma
Drug class: VEGF/VEGFR inhibitors
Bevacizumab systemic is used in the treatment of:
- Breast Cancer
- Breast Cancer, Metastatic
- Cervical Cancer
- Colorectal Cancer
- Fallopian Tube Cancer
- Glioblastoma Multiforme
- Hepatocellular Carcinoma
- Macular Degeneration
- Malignant Glioma
- Neurofibromatosis
- Non Small Cell Lung Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Peritoneal Cancer
- Renal Cell Carcinoma
- Solid Tumors
bevacizumab ophthalmic
Drug class: anti-angiogenic ophthalmic agents
Bevacizumab ophthalmic is used in the treatment of:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.